J9040Bleomycin sulfate injection
Published CMS Medicare Part B payment-limit context for J9040, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$24.838
per 15 UNITS · Medicare Part B
Up 49.6%from $16.598 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$25.9916$15.4444
2024-Q4: $24.684; 2025-Q1: $20.911; 2025-Q2: $21.556; 2025-Q3: $20.899; 2025-Q4: $21.525; 2026-Q1: $23.018; 2026-Q2: $16.598; 2026-Q3: $24.838
No current FDA shortage matchThe latest completed FDA data has no affected record matching the Bleomycin Sulfate ingredient family (FDA data as of August 20, 2026).
Bleomycin Sulfate
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.